Form 4 for NEO NEOGENOMICS INC
Accepted 2022-12-07 00:00:00 ET · period of report 2022-12-05 · accession 0001077183-22-000202 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-07 | 2022-12-05 | NEO | Sherman Jeffrey Scott | CFO | A - Grant | $0.00 | +133.8K | 133.8K | New | $0 |
| D | 2022-12-07 | 2022-12-05 | NEO | Sherman Jeffrey Scott | CFO | A - Grant | $0.00 | +249.2K | 249.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-05 | A | A | 44,603 | $0.00 | 44,603 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-05 | A | A | 89,206 | $0.00 | 133,809 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-12-05 | A | A | 249,169 | $0.00 | 249,169 | D | $11.62 · — to 2029-12-05 | 249,169 Common Stock | (F3) On December 5, 2022, Mr. Sherman was granted 249,169 stock options. These awards vest ratably over four years with the first tranche vesting on December 7, 2023. |